Yushin Company (6482) FY2026 Q3 Earnings Report

Quick View

Executive Summary

Cumulative results for FY2026 Q3 reflected declines in both revenue and earnings, with profitability deteriorating significantly. Revenue was ¥16.75B (-10.8% YoY), Operating Income was ¥0.30B (-78.4%), Ordinary Income was ¥0.38B (-72.2%), and Net Income attributable to owners of the parent was ¥0.24B (-74.8%). The decline in earnings, substantially exceeding the decrease in revenue, indicates that operating leverage deteriorated due to the fixed burden of selling, general and administrative expenses. The primary factors were a sharp decline in revenue from the European Business and its shift to a segment loss.

Factors Affecting Earnings

【Revenue】Revenue was ¥16.75B, down -10.8% YoY. By segment, Japan generated ¥10.78B (64.4% of total, -1.6% YoY), Asia ¥4.13B (24.7%, -0.2%), the United States ¥3.06B (18.3%, -1.0%), and Europe ¥2.14B (12.8%, -47.8%), with the sharp decline in Europe driving the overall revenue decrease.

【Profit and Loss】Gross profit was ¥6.42B, securing a gross margin of 38.4%; however, SG&A expenses of ¥6.12B absorbed nearly all gross profit, reducing Operating Income to ¥0.30B, equivalent to an Operating Margin of 1.8%. While segment profit in Japan of ¥0.54B and Asia of ¥0.34B provided support, Europe recorded a loss of ¥0.32B and the United States also recorded a loss of ¥0.06B. The shift to a loss in Europe significantly depressed company-wide earnings. Ordinary Income of ¥0.38B included ¥0.08B in non-operating income, including interest income, dividend income, and foreign exchange gains. There was a gap of approximately ¥0.89B between Net Income of ¥0.24B and Comprehensive Income of ¥1.13B attributable to owners of the parent, primarily due to foreign currency translation adjustments of ¥0.79B. The company posted declines in both revenue and earnings, with reduced SG&A absorption and deterioration in the European Business representing structural challenges.

Segment Analysis

Japan was the largest source of earnings, with revenue of ¥10.78B (64.4% of total) and Operating Income of ¥0.54B (Operating Margin of 5.0%); however, profit approximately halved from ¥1.05B in the prior year. Asia generated revenue of ¥4.13B and Operating Income of ¥0.34B (Operating Margin of 8.3%), maintaining the highest Operating Margin among all segments and remaining relatively stable. The United States generated revenue of ¥3.06B but recorded an Operating Loss of ¥0.06B (Operating Margin of -1.9%), indicating deteriorating profitability. Europe generated revenue of ¥2.14B (-47.8% YoY) and recorded an Operating Loss of ¥0.32B (Operating Margin of -14.9%), representing a substantial shift from a profit in the prior year to a loss. In terms of structural changes by region, the rapid deterioration of the European Business was the largest factor behind the deterioration in company-wide results.

Key Financial Indicators

【Profitability】The Operating Margin was 1.8% and the Net Profit Margin was 1.5%, both representing significantly lower levels than in the prior year. ROE was 0.8% (under DuPont decomposition: Net Profit Margin of 1.5% × Total Asset Turnover of 0.414x × Financial Leverage of 1.14x), indicating that the low profit margin is constraining capital efficiency.【Cash Flow Quality】Although Operating Cash Flow (OCF) has not been disclosed, Comprehensive Income of ¥1.20B substantially exceeded Net Income of ¥0.27B. The difference was primarily attributable to OCI fluctuations from foreign currency translation adjustments of ¥0.79B.【Investment Efficiency】ROIC is estimated to be in the 1% range, with the low Operating Margin and Total Asset Turnover depressing returns on invested capital.【Financial Soundness】The Equity Ratio was 87.9%. Net assets of ¥35.57B against total assets of ¥40.49B indicate a capital structure centered on equity, with conservative Financial Leverage. Cash and deposits totaled ¥10.88B, accounting for 26.9% of total assets and supporting financial resilience.

Cash Flow Analysis

As the statement of cash flows has not been disclosed, funding trends are analyzed based on changes in the balance sheet. Cash and deposits decreased to ¥10.88B from ¥11.69B in the prior year, while the Equity Ratio remained high at 87.9%. The company continues to maintain a conservative capital structure, with Net Assets of ¥35.57B against Total Liabilities of ¥4.91B. Accounts receivable totaled ¥5.46B, while inventories—comprising finished goods, raw materials, and work in process—amounted to approximately ¥7.91B. Despite the sharp decline in Operating Income, inventory levels increased from the prior year. This suggests that funds may be becoming more heavily tied up in working capital; therefore, progress in inventory reduction and accounts receivable collection, accompanied by improved cash flow, will be important indicators in assessing the realization of an earnings recovery.

Quality of Earnings

Current-period profit included a gain on the sale of property, plant and equipment of ¥0.02B as an extraordinary gain, although the amount was small and its impact on the recurring earnings structure was limited. Non-operating income of ¥0.08B comprised dividend income of ¥0.02B, foreign exchange gains of ¥0.01B, interest income of ¥0.02B, and other items. Non-operating expenses were negligible, and the difference between Ordinary Income and Operating Income was primarily attributable to relatively stable interest and dividend income. Meanwhile, there was a substantial gap between consolidated Net Income of ¥0.27B and Comprehensive Income of ¥1.20B, primarily due to foreign currency translation adjustments of ¥0.79B. This should be noted as an accounting fluctuation associated with the valuation of overseas subsidiaries’ assets rather than a measure of the business’s underlying earnings power. Although a gross margin of 38.4% was maintained, SG&A expenses absorbed nearly all gross profit, meaning that the fixed nature of the cost structure is likely to amplify earnings volatility in terms of Operating Income quality.

Earnings Forecasts and Guidance

No revisions have been made to the Full-Year forecasts of Revenue of ¥23.00B, Operating Income of ¥1.50B, and Ordinary Income of ¥1.50B. The cumulative Q3 progress rate was generally steady at 72.8% for Revenue; however, progress toward Operating Income was only 20.3%, and progress toward Ordinary Income was similarly low. To achieve the Full-Year forecast, approximately ¥1.20B in Operating Income must be generated in Q4, an amount approximately four times the cumulative result of ¥0.30B for the first three quarters. This progress gap indicates that achieving the forecast depends on the extent to which the European Business can be rebuilt and SG&A expenses optimized during Q4.

Shareholder Returns

The Q2 dividend was ¥10.00 per share, and the Full-Year dividend forecast remains unchanged at ¥20.00 per share. Based on consolidated Net Income of ¥0.27B (Net Income attributable to owners of the parent of ¥0.24B), the estimated Payout Ratio based on total dividends exceeds 100%, indicating a heavy burden when measured solely against the current-period earnings level. However, the company has a strong financial foundation, with cash and deposits of ¥10.88B and an Equity Ratio of 87.9%; its cash balance may support the funding of dividends in the near term. No disclosure has been made regarding share repurchases, and shareholder returns are evaluated based on the Payout Ratio.

Risk Factors

1. Deterioration in European Business profitability: Revenue in the European segment declined sharply by -47.8% YoY, and the segment shifted to an Operating Loss of ¥0.32B (Operating Margin of -14.9%). This was the largest deterioration factor among regional results, and the pace of recovery will influence company-wide performance.

2. Declining working capital efficiency: Inventories remained high, comprising raw materials of ¥5.35B, finished goods of ¥1.31B, and work in process of ¥1.28B. This creates risks of valuation losses and funds becoming tied up amid demand fluctuations. Progress in reducing inventory during a period of declining revenue remains a key challenge.

3. Progress gap in achieving the Full-Year forecast: Progress toward Operating Income and Net Income remained in the 20% range, creating a significant gap versus the 72.8% progress rate for Revenue. Substantial earnings improvement in Q4 is assumed, and achievement will require stronger SG&A absorption and improvement in the European Business.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The company’s profitability metrics are substantially below the industry median and rank in the lower tier even within the manufacturing industry.

Growth and Capital Efficiency

While many peers secured revenue growth, the company experienced a revenue decline and ranks in the lower tier of the industry in terms of growth.

※Source: Compiled by the Company

Key Points of the Financial Results

1. The company has a strong financial position, with an Equity Ratio of 87.9% and cash and deposits of ¥10.88B. Accordingly, concerns regarding short-term financial safety remain limited even amid deteriorating profitability.

2. The deterioration in results was centered on the European Business shifting to a loss and declining SG&A absorption. Recovery in Revenue alone may therefore be insufficient to improve Operating Income.

3. Progress toward the Full-Year forecasts for Operating Income and Net Income is substantially below progress toward the Revenue forecast. The pace of earnings recovery in Q4 will be closely monitored as a prerequisite for achieving the Full-Year forecasts.

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q3 performance was weak, with a sharp contraction in profitability despite a still exceptionally liquid and lightly leveraged balance sheet. Nine-month revenue declined 10.8% year on year to ¥16.75bn. Operating income fell 78.4% to ¥0.30bn, while profit attributable to owners of parent declined 74.8% to ¥0.24bn. The operating margin compressed by 568bp year on year, to 1.8% from 7.5%. Net margin similarly fell by 370bp to 1.5% from 5.2%. Gross profit declined 14.3% to ¥6.42bn, faster than the revenue decline, and gross margin narrowed by 153bp to 38.4%. SG&A expense was broadly flat at ¥6.12bn, declining only 0.5%, which created substantial negative operating leverage against lower sales. Japan remained the core business by segment profit contribution, but its segment profit declined 48.7% to ¥0.54bn. Europe was the principal drag, as external sales fell 47.8% to ¥2.06bn and the segment moved to a ¥0.32bn loss from a ¥0.18bn profit. Asia was comparatively resilient, with segment profit increasing 10.2% to ¥0.34bn despite a 0.2% revenue decline. The US segment remained loss-making, although its loss narrowed modestly to ¥0.06bn from ¥0.07bn. Consolidated operating income was also burdened by a ¥0.20bn segment adjustment, largely reflecting inventory-related adjustments, compared with a ¥0.05bn burden a year earlier. Non-operating income of ¥0.81bn provided meaningful support to ordinary income, including ¥0.23bn of interest income, ¥0.19bn of dividend income and ¥0.14bn of foreign-exchange gains. An extraordinary gain of ¥0.19bn also supported pretax income, although reported net profit remains primarily constrained by weak operating earnings. Comprehensive income was materially stronger than net income at ¥1.20bn, supported by foreign-currency translation and securities valuation movements. Management retained its full-year forecast, but Q3 progress is well below the normal 75% seasonal benchmark for profit measures. The principal forward implication is that delivery of the unchanged forecast requires a pronounced Q4 recovery in operating earnings, particularly through stabilization in Europe, improved capacity and cost absorption, and release of working-capital intensity.

Profitability Analysis

The annualized DuPont decomposition shows ROE of 0.9%, comprising a 1.5% net profit margin, 0.552x asset turnover and 1.14x financial leverage. The principal source of weak shareholder returns is profitability rather than leverage: the balance sheet is conservatively financed, so leverage cannot compensate for the low margin. The net margin deterioration to 1.5% from approximately 5.2% in the prior-year nine-month period is the largest negative DuPont movement. Asset turnover is also subdued because the ¥16.75bn nine-month revenue base is modest relative to ¥40.49bn of assets; the reported 0.552x measure is annualized. Gross margin fell to 38.4% from 39.9%, indicating that the earnings pressure was not solely attributable to SG&A. More importantly, SG&A was almost unchanged at ¥6.12bn while revenue fell ¥2.04bn, causing operating income to fall by ¥1.10bn. This negative operating leverage reduced EBIT margin to 1.8%, below the 5% efficiency threshold highlighted in the quality alert. The low-operating-efficiency alert is rooted in the inability of the current revenue base to absorb the fixed or semi-fixed SG&A structure. Its impact is material because minor volume or price pressure now has an amplified effect on earnings and capital returns. ROIC of 1.1%, also flagged as low, confirms that the earnings weakness extends beyond accounting ROE and reflects inadequate returns on the operating capital employed. The low ROIC reduces strategic flexibility because reinvestment at the current return profile is unlikely to be value-accretive without a margin recovery. Ordinary income of ¥0.38bn exceeded operating income by ¥0.08bn due to investment and financial income, but this support does not resolve the underlying operating-margin issue. The tax burden was 0.606, equivalent to a 31.9% effective tax rate, while the interest burden of 1.328x reflects net non-operating income rather than debt-service stress. Goodwill of ¥0.43bn is only 1.2% of equity and 1.1% of assets, so M&A accounting exposure is not a material driver of the low reported profitability. The profitability recovery case therefore rests predominantly on restoring European profitability, protecting gross margin, and resizing or improving utilization of the SG&A base.

Growth Assessment

Revenue contraction was broad but highly uneven by geography. Japan's external revenue declined 1.6% to ¥7.75bn, and its segment profit fell to ¥0.54bn from ¥1.05bn, indicating material margin pressure despite relatively resilient sales. US external revenue was nearly stable at ¥3.04bn, down 0.5%, but the segment remained loss-making at ¥0.06bn. Asia external revenue declined only 0.2% to ¥3.90bn, while segment profit rose to ¥0.34bn from ¥0.31bn, making Asia the clearest source of relative earnings resilience. Europe experienced the most severe deterioration, with external revenue falling ¥1.89bn to ¥2.06bn and segment profit declining by ¥0.50bn to a ¥0.32bn loss. Europe therefore accounts for most of the consolidated revenue contraction and is the highest-priority operating turnaround area. The full-year sales forecast is ¥23.0bn, and Q3 cumulative progress is 72.8%, only 2.2 percentage points below the standard 75% run rate. In contrast, operating-income progress is just 20.2% against the ¥1.50bn forecast, 54.8 percentage points below the standard Q3 benchmark. Ordinary-income progress is 25.5%, and parent net-income progress is 24.4%, both also far below a normal 75% run rate. Achieving guidance would require Q4 revenue of ¥6.25bn and operating income of ¥1.20bn, implying a 19.2% Q4 operating margin. That required margin is far above the 1.8% nine-month margin and indicates that the unchanged forecast depends on a substantial year-end improvement. Forecast achievement also requires Q4 parent net income of ¥0.76bn, compared with ¥0.24bn generated over the first nine months. Revenue progress itself is broadly consistent with the forecast, but the earnings run rate is not. The lack of forecast revision therefore makes Q4 execution, regional mix and gross-margin recovery the central earnings variables.

Financial Health

Financial health is strong from a liquidity and solvency perspective. Current assets of ¥25.75bn exceed current liabilities of ¥4.19bn by ¥21.57bn, producing a current ratio of 615.1% and a quick ratio of 583.8%. Cash and deposits of ¥10.88bn alone are more than 2.6 times current liabilities. Total liabilities are only ¥4.91bn, equivalent to 12.1% of total assets, while total equity is ¥35.57bn. The debt-to-equity ratio is a conservative 0.14x, well below the 2.0x warning threshold. There is no apparent short-term maturity mismatch because liquid current assets substantially exceed current liabilities. Accounts payable of ¥1.54bn and electronically recorded obligations of ¥0.36bn provide part of the operating funding base, while advances received total ¥0.72bn. The capital adequacy ratio improved to 86.9% from 85.5%, supported by accumulated other comprehensive income. Investment securities increased ¥2.09bn, or 37.2% year on year, to ¥0.77bn; this modest portfolio remains only 1.9% of total assets but adds exposure to market-value movements. Treasury stock increased by ¥0.39bn, or 28.7%, to negative ¥1.75bn, representing 4.3% of total assets. The increase in treasury shares indicates capital deployment through repurchases or related share transactions, which should be assessed alongside the weak current earnings return. Goodwill and intangible assets total ¥2.70bn, or 6.7% of assets, and goodwill is immaterial relative to equity, limiting balance-sheet dependence on acquisition values. Net defined-benefit liability is ¥0.13bn and product-warranty provision is ¥0.12bn, both modest relative to total equity. Overall, balance-sheet resilience is a clear offset to weak operating returns, although excess liquidity does not itself remedy the low ROIC.

Notable B/S Changes

Investment securities: +¥2.09bn (+37.2%) to ¥0.77bn — increased exposure to securities valuation movements, although the balance remains modest at 1.9% of total assets. Treasury stock: -¥0.39bn (-28.7%) to -¥1.75bn — additional capital deployment to repurchased or held shares; this warrants monitoring alongside low current ROE and ROIC.

Cash Flow Quality

Working-capital efficiency is the principal cash-conversion risk indicated by the reported metrics. Annualized receivable days are 89 days, above the 60-day quality-alert threshold and above the 45-day manufacturing efficiency benchmark. The root cause of the high-DSO alert is that trade receivables of ¥5.46bn remain substantial relative to the current sales run rate. This is particularly relevant because revenue has declined, making timely collection and credit discipline more important to cash generation. Annualized inventory days are 210 days, far above the 90-day warning level. The high-inventory-days alert indicates that capital is tied up in inventory for an extended production and sales cycle, increasing the risk of lower cash conversion and potential inventory valuation pressure if demand remains weak. Finished goods were ¥1.31bn and work in process was ¥1.28bn, underscoring the importance of aligning production with the regional demand environment. The annualized cash conversion cycle is 259 days, exceeding the 120-day warning threshold by a wide margin. This long-CCC alert is driven by the combined effect of slow collections and elevated inventory duration, and it is a material concern despite the company's large cash balance. A lengthy operating cash cycle can absorb liquidity during periods of sales weakness and raises the importance of inventory discipline, production scheduling and collection performance. Inventory-related segment adjustments were a ¥0.20bn negative reconciliation item, materially worse than the ¥0.05bn negative adjustment in the prior year, reinforcing the need to monitor inventory-related earnings conversion. Cash and deposits declined ¥0.81bn year on year to ¥10.88bn while reported inventory increased ¥1.48bn, consistent with greater working-capital demands. The cash-quality focus should therefore be on reducing DSO and DIO rather than on immediate financing capacity, which remains strong.

Dividend Sustainability

The stated interim dividend is ¥10.00 per share, and the full-year forecast calls for ¥20.00 per share. The calculated dividend payout ratio is 146.1%, exceeding both current earnings and the 100% sustainability warning threshold. This elevated payout ratio is rooted in the sharp decline in nine-month profitability rather than in an aggressive balance-sheet structure. On the current earnings base, the dividend commitment relies on retained earnings capacity and the company's substantial liquidity rather than on contemporaneous profit coverage. Retained earnings of ¥29.70bn and cash and deposits of ¥10.88bn provide considerable near-term financial capacity. However, a payout ratio above 100% is not a recurring earnings-funded distribution profile if low profitability persists. The full-year ¥20.00 DPS forecast equates to an implied payout ratio of roughly 68% against forecast EPS of ¥29.38, which remains above the stated sub-60% sustainability benchmark but is materially lower than the current nine-month ratio. Thus, dividend sustainability depends heavily on achieving the forecast earnings rebound in Q4. The increase in treasury stock also indicates that shareholder-return decisions should be considered in the context of total capital deployment, although a total return ratio cannot be quantified from the reported data. The key dividend issue is not balance-sheet capacity but whether operating income can recover sufficiently to restore earnings coverage.

Risk Assessment

Business risks include High priority — European execution risk: external revenue fell 47.8% year on year to ¥2.06bn and the segment shifted to a ¥0.32bn loss, making stabilization of European demand, production utilization and cost absorption critical., High priority — margin and operating-leverage risk: gross margin contracted 153bp and largely flat SG&A against a 10.8% revenue decline compressed the operating margin to 1.8%., High priority — manufacturing working-capital risk: annualized DSO of 89 days, DIO of 210 days and a 259-day cash conversion cycle indicate slow conversion of production and sales into cash., Medium priority — inventory and demand-planning risk: elevated inventory duration can lead to discounting, valuation pressure or further production adjustments if end-market demand does not improve., Medium priority — foreign-exchange and overseas-market risk: the group has material operations across the US, Asia and Europe, while foreign-exchange gains of ¥0.14bn were meaningful relative to ¥0.30bn operating income..

Financial risks include Low priority — profitability-funded dividend risk: the stated 146.1% payout ratio exceeds current earnings coverage, although liquidity and retained earnings provide near-term support., Low priority — market-value risk in financial assets: investment securities increased 37.2% to ¥0.77bn, and securities valuation gains contributed to comprehensive income., Low priority — capital-allocation risk: additional treasury stock increased the capital committed to shareholder returns while annualized ROE and ROIC remain only 0.9% and 1.1%, respectively., Low priority — goodwill impairment risk: goodwill is only 1.2% of equity and therefore does not represent a material balance-sheet vulnerability at present..

Key concerns include The low-operating-efficiency quality alert is material: a 1.8% EBIT margin is below the 5% threshold and leaves little protection against further sales or cost pressure., The capital-efficiency quality alert is material: ROIC of 1.1% is below 5%, showing that current operating profits are insufficient relative to the capital employed., The high-receivable-days quality alert requires close monitoring: annualized DSO of 89 days increases cash-collection and customer-credit sensitivity., The high-inventory-days quality alert requires close monitoring: annualized DIO of 210 days points to a long production-to-sale cycle and possible demand-planning inefficiency., The long-cash-conversion-cycle quality alert is material: the 259-day annualized CCC can restrain cash generation even though the balance sheet is highly liquid., Full-year operating-income guidance requires ¥1.20bn of Q4 operating income and a 19.2% Q4 operating margin, creating a high execution threshold..

Investment Implications

Key takeaways include The central earnings issue is operating-margin recovery: revenue progress toward guidance is near the normal Q3 run rate, but profit progress is substantially behind., Japan remains the core earnings contributor and Asia is relatively resilient, while Europe is the principal source of consolidated deterioration., The balance sheet provides substantial downside resilience, with a 615.1% current ratio, 0.14x debt-to-equity and ¥10.88bn of cash and deposits., Low annualized ROE of 0.9%, low ROIC of 1.1% and a 1.8% EBIT margin indicate weak current capital productivity., Working-capital normalization is a key prerequisite for stronger cash conversion and a more durable earnings recovery., The dividend is balance-sheet supported in the near term, but its longer-term earnings coverage depends on achievement of the forecast recovery..

Metrics to watch include European external revenue and segment profit, Consolidated gross margin and SG&A-to-sales ratio, Q4 operating income versus the ¥1.20bn implied requirement, Annualized DSO of 89 days, DIO of 210 days and CCC of 259 days, Inventory-related consolidation adjustments, Operating margin, annualized ROE and ROIC, Dividend earnings coverage and changes in treasury stock.

Regarding relative positioning, YUSHIN is financially conservative relative to common solvency benchmarks, but its current operating and capital efficiency profile is weak: the 1.8% EBIT margin, 0.9% annualized ROE, 1.1% ROIC and extended working-capital cycle place operating performance below a healthy manufacturing benchmark despite substantial balance-sheet strength.